RAGE silencing deters CML-AGE induced inflammation and TLR4 expression in endothelial cells

Microvascular and Macrovascular Complications of Diabetes

Michael J. Fowler · Clinical Diabetes · 2008 · 1.9K citations

Type 1, Diabetic Retinopathy, Diabetes Management +14

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

Ann Marie Schmidt, Shi Du Yan, Shi Fang Yan et al. · Journal of Clinical Investigation · 2001 · 1K citations · Full text

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

Mohan R. Dasu, Sridevi Devaraj, Samuel Park et al. · Diabetes Care · 2010 · 567 citations · Full text

Advanced glycation end products

Paraskevi Gkogkolou, Markus Böhm · Dermato-Endocrinology · 2012 · 540 citations · Full text

Anti-aging, Aging, Glycobiology +17

N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins

S. Jayarama Reddy, Kevin J. Wells‐Knecht, Suzanne R. Thorpe et al. · Biochemistry · 1995 · 519 citations